Sensei Biotherapeutics Inc. (SNSE) NASDAQ
$1.06 (0.03) (-2.75%)
Market Cap: $27.33M
As of 03/28/24 03:57 PM EDT. Market closed.
Sensei Biotherapeutics Inc. (SNSE)
NASDAQ
$1.06
(0.03) (-2.75%)
Market Cap: $27.33M
As of 03/28/24 03:57 PM EDT. Market closed.
sensei biotherapeutics is an innovator in the field of next-generation cancer immunotherapies. sensei has pioneered a proprietary immuno-oncology technology platform, called spirit, to aid the immune system in the detection and elimination of cancer. the presence of subtle differences in antigen expression between cancer and normal is key to this process the spirit platform overcomes disabled ... read more
sensei biotherapeutics is an innovator in the field of next-generation cancer immunotherapies. sensei has pioneered a proprietary immuno-oncology technology platform, called spirit, to aid the immune system in the detection and elimination of cancer. the presence of subtle differences in antigen expression between cancer and normal is key to this process the spirit platform overcomes disabled immune recognition caused by cancer. the immune system has evolved to protect its host from foreign pathogens, effectively distinguishing healthy ‘self’ tissues from ‘non-self’. cancer is a unique challenge to the immune system. it arises from ‘self’ making immune recognition challenging, yet it is known to be altered. immune recognition of the subtle differences between ‘self’ and ‘non-self’ is key to effective cancer immunotherapy. headquartered in gaithersburg, md, sensei has built a unique and proprietary approach in-house and in collaboration with key academic collaborators at brown universit read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
van der Horst Edward | CHIEF SCIENTIFIC OFFICER | Feb 15, 2024 | Option Exercise | $0.79 | 2,843 | 2,246 | 56,070 | Feb 16, 2024, 06:37 PM |
Celebi John | PRESIDENT AND CEO | Feb 15, 2024 | Option Exercise | $0.79 | 5,891 | 4,654 | 105,420 | Feb 16, 2024, 06:28 PM |
Colgan Erin | CHIEF FINANCIAL OFFICER | Feb 15, 2024 | Option Exercise | $0.79 | 3,627 | 2,865 | 67,462 | Feb 16, 2024, 06:25 PM |
Celebi John | President and CEO | Sep 11, 2023 | Buy | $0.85 | 500 | 425 | 111,311 | Sep 13, 2023, 08:43 AM |
Gallagher Patrick Stephen | Chief Business Officer | Feb 15, 2023 | Option Exercise | $1.50 | 9,383 | 14,075 | 34,130 | Sep 11, 2023, 05:34 PM |
van der Horst Edward | Chief Scientific Officer | Feb 15, 2023 | Option Exercise | $1.50 | 9,525 | 14,288 | 52,913 | Sep 11, 2023, 05:33 PM |
Celebi John | President and CEO | Feb 15, 2023 | Option Exercise | $1.50 | 20,492 | 30,738 | 110,811 | Sep 11, 2023, 05:33 PM |
Colgan Erin | Chief Financial Officer | Feb 15, 2023 | Option Exercise | $1.50 | 10,943 | 16,415 | 68,089 | Sep 11, 2023, 05:31 PM |
Cambrian BioPharma Inc | 10% Owner | Jul 31, 2023 | Option Exercise | $1.26 | 1,587,302 | 2,000,001 | 3,653,120 | Aug 02, 2023, 05:09 PM |
Peyer James | Director | Jul 31, 2023 | Option Exercise | $1.26 | 1,587,302 | 2,000,001 | 3,653,120 | Aug 02, 2023, 05:06 PM |
Apeiron Investment Group Ltd. | 10% Owner | Jun 01, 2023 | Sale | $1.58 | 955,738 | 1,510,066 | 0 | Jun 02, 2023, 05:03 PM |
Apeiron Investment Group Ltd. | 10% Owner | Jun 01, 2023 | Sale | $1.58 | 2,485,923 | 3,927,758 | 0 | Jun 02, 2023, 05:03 PM |
Apeiron Investment Group Ltd. | 10% Owner | Feb 23, 2023 | Buy | $1.61 | 2,200 | 3,539 | 2,485,923 | Feb 27, 2023, 08:10 PM |
Peyer James | Director | Mar 02, 2022 | Buy | $3.20 | 1,203 | 3,850 | 5,231,488 | Jun 10, 2022, 02:18 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 02, 2022 | Buy | $3.20 | 1,203 | 3,850 | 5,231,488 | Jun 10, 2022, 02:17 PM |
Peyer James | Director | Mar 23, 2021 | Buy | $14.34 | 9,500 | 136,230 | 4,798,293 | Apr 21, 2022, 04:25 PM |
Peyer James | Director | Feb 18, 2021 | Buy | $19.75 | 752 | 14,852 | 4,690,905 | Apr 21, 2022, 04:22 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 23, 2021 | Buy | $14.34 | 9,500 | 136,230 | 4,798,293 | Apr 21, 2022, 04:19 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 18, 2021 | Buy | $19.75 | 752 | 14,852 | 4,690,905 | Apr 21, 2022, 04:17 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 02, 2022 | Buy | $3.20 | 1,203 | 3,850 | 5,231,989 | Mar 02, 2022, 01:42 PM |
Peyer James | Director | Mar 02, 2022 | Buy | $3.20 | 1,203 | 3,850 | 5,231,989 | Mar 02, 2022, 01:40 PM |
Peyer James | Director | Mar 01, 2022 | Buy | $3.60 | 2,458 | 8,849 | 5,230,786 | Mar 01, 2022, 06:55 PM |
Peyer James | Director | Feb 28, 2022 | Buy | $3.60 | 42 | 151 | 5,228,328 | Mar 01, 2022, 06:55 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 01, 2022 | Buy | $3.60 | 2,458 | 8,849 | 5,230,786 | Mar 01, 2022, 06:53 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 28, 2022 | Buy | $3.60 | 42 | 151 | 5,228,328 | Mar 01, 2022, 06:53 PM |
Peyer James | Director | Feb 25, 2022 | Buy | $3.65 | 2,500 | 9,125 | 5,228,286 | Feb 28, 2022, 04:53 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 25, 2022 | Buy | $3.65 | 2,500 | 9,125 | 5,228,286 | Feb 28, 2022, 04:50 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 24, 2022 | Buy | $3.63 | 15,000 | 54,450 | 5,225,786 | Feb 24, 2022, 07:15 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 23, 2022 | Buy | $3.80 | 2,500 | 9,500 | 5,210,786 | Feb 24, 2022, 07:15 PM |
Peyer James | Director | Feb 24, 2022 | Buy | $3.63 | 15,000 | 54,450 | 5,225,786 | Feb 24, 2022, 07:12 PM |
Peyer James | Director | Feb 23, 2022 | Buy | $3.80 | 2,500 | 9,500 | 5,210,786 | Feb 24, 2022, 07:12 PM |
Peyer James | Director | Feb 18, 2022 | Buy | $3.97 | 15,000 | 59,550 | 5,208,286 | Feb 22, 2022, 11:36 AM |
Peyer James | Director | Feb 17, 2022 | Buy | $4.17 | 4,949 | 20,637 | 5,193,286 | Feb 22, 2022, 11:36 AM |
Cambrian BioPharma Inc | 10% Owner | Feb 18, 2022 | Buy | $3.97 | 15,000 | 59,550 | 5,208,286 | Feb 22, 2022, 11:35 AM |
Cambrian BioPharma Inc | 10% Owner | Feb 17, 2022 | Buy | $4.17 | 4,949 | 20,637 | 5,193,286 | Feb 22, 2022, 11:35 AM |
Cambrian BioPharma Inc | 10% Owner | Feb 16, 2022 | Buy | $4.25 | 2,551 | 10,842 | 5,188,337 | Feb 16, 2022, 06:59 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 14, 2022 | Buy | $4.18 | 10,000 | 41,800 | 5,185,786 | Feb 16, 2022, 06:59 PM |
Peyer James | Director | Feb 16, 2022 | Buy | $4.25 | 2,551 | 10,842 | 5,188,337 | Feb 16, 2022, 06:54 PM |
Peyer James | Director | Feb 14, 2022 | Buy | $4.18 | 10,000 | 41,800 | 5,185,786 | Feb 16, 2022, 06:54 PM |
Peyer James | Director | Feb 11, 2022 | Buy | $4.40 | 12,500 | 55,000 | 5,175,786 | Feb 14, 2022, 07:19 PM |
Peyer James | Director | Feb 10, 2022 | Buy | $4.58 | 5,000 | 22,900 | 5,163,286 | Feb 14, 2022, 07:19 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 10, 2022 | Buy | $4.58 | 5,000 | 22,900 | 5,163,286 | Feb 14, 2022, 07:18 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 11, 2022 | Buy | $4.40 | 12,500 | 55,000 | 5,175,786 | Feb 14, 2022, 07:18 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 08, 2022 | Buy | $4.33 | 10,000 | 43,300 | 5,158,286 | Feb 08, 2022, 06:42 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 04, 2022 | Buy | $4.45 | 2,500 | 11,125 | 5,148,286 | Feb 08, 2022, 06:42 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 03, 2022 | Buy | $4.65 | 17,500 | 81,375 | 5,145,786 | Feb 08, 2022, 06:42 PM |
Peyer James | Director | Feb 08, 2022 | Buy | $4.33 | 10,000 | 43,300 | 5,158,286 | Feb 08, 2022, 06:40 PM |
Peyer James | Director | Feb 04, 2022 | Buy | $4.45 | 2,500 | 11,125 | 5,148,286 | Feb 08, 2022, 06:40 PM |
Peyer James | Director | Feb 03, 2022 | Buy | $4.65 | 17,500 | 81,375 | 5,145,786 | Feb 08, 2022, 06:40 PM |
Cambrian BioPharma Inc | 10% Owner | Jan 28, 2022 | Buy | $4.22 | 8,900 | 37,558 | 5,128,286 | Jan 31, 2022, 11:30 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 27, 2022 | Buy | $4.31 | 6,100 | 26,291 | 5,119,386 | Jan 31, 2022, 11:30 AM |
Peyer James | Director | Jan 27, 2022 | Buy | $4.31 | 6,100 | 26,291 | 5,119,386 | Jan 31, 2022, 11:26 AM |
Peyer James | Director | Jan 28, 2022 | Buy | $4.22 | 8,900 | 37,558 | 5,128,286 | Jan 31, 2022, 11:26 AM |
Peyer James | Director | Jan 26, 2022 | Buy | $4.62 | 29,900 | 138,138 | 5,113,286 | Jan 27, 2022, 10:31 AM |
Peyer James | Director | Jan 25, 2022 | Buy | $4.86 | 20,100 | 97,686 | 5,083,386 | Jan 27, 2022, 10:31 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 26, 2022 | Buy | $4.62 | 29,900 | 138,138 | 5,113,286 | Jan 27, 2022, 10:26 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 25, 2022 | Buy | $4.86 | 20,100 | 97,686 | 5,083,386 | Jan 27, 2022, 10:26 AM |
Peyer James | Director | Jan 24, 2022 | Buy | $4.69 | 22,707 | 106,496 | 5,063,286 | Jan 25, 2022, 09:14 AM |
Peyer James | Director | Jan 21, 2022 | Buy | $4.94 | 24,703 | 122,033 | 5,040,579 | Jan 25, 2022, 09:14 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 24, 2022 | Buy | $4.69 | 22,707 | 106,496 | 5,063,286 | Jan 25, 2022, 09:12 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 21, 2022 | Buy | $4.94 | 24,703 | 122,033 | 5,040,579 | Jan 25, 2022, 09:12 AM |
Peyer James | Director | Jan 20, 2022 | Buy | $5.17 | 20,000 | 103,400 | 5,015,876 | Jan 21, 2022, 06:20 PM |
Peyer James | Director | Jan 19, 2022 | Buy | $4.97 | 10,244 | 50,913 | 4,995,876 | Jan 21, 2022, 06:20 PM |
Cambrian BioPharma Inc | 10% Owner | Jan 20, 2022 | Buy | $5.17 | 20,000 | 103,400 | 5,015,876 | Jan 21, 2022, 06:16 PM |
Cambrian BioPharma Inc | 10% Owner | Jan 19, 2022 | Buy | $4.97 | 10,244 | 50,913 | 4,995,876 | Jan 21, 2022, 06:16 PM |
Peyer James | Director | Jan 18, 2022 | Buy | $5.08 | 10,000 | 50,800 | 4,985,632 | Jan 20, 2022, 09:07 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 18, 2022 | Buy | $5.08 | 10,000 | 50,800 | 4,985,632 | Jan 20, 2022, 09:05 AM |
Peyer James | Director | Jan 14, 2022 | Buy | $4.99 | 6,219 | 31,033 | 4,975,632 | Jan 18, 2022, 10:20 AM |
Peyer James | Director | Jan 13, 2022 | Buy | $5.13 | 19,953 | 102,359 | 4,969,413 | Jan 18, 2022, 10:20 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 14, 2022 | Buy | $4.99 | 6,219 | 31,033 | 4,975,632 | Jan 18, 2022, 10:17 AM |
Cambrian BioPharma Inc | 10% Owner | Jan 13, 2022 | Buy | $5.13 | 19,953 | 102,359 | 4,969,413 | Jan 18, 2022, 10:17 AM |
Peyer James | Director | Jan 11, 2022 | Buy | $5.18 | 10,845 | 56,177 | 4,940,258 | Jan 13, 2022, 04:14 PM |
Peyer James | Director | Jan 12, 2022 | Buy | $5.22 | 9,202 | 48,034 | 4,949,460 | Jan 13, 2022, 04:14 PM |
Cambrian BioPharma Inc | 10% Owner | Jan 12, 2022 | Buy | $5.22 | 9,202 | 48,034 | 4,949,460 | Jan 13, 2022, 04:13 PM |
Cambrian BioPharma Inc | 10% Owner | Jan 11, 2022 | Buy | $5.18 | 10,845 | 56,177 | 4,940,258 | Jan 13, 2022, 04:13 PM |
Peyer James | Director | Jan 10, 2022 | Buy | $5.28 | 10,000 | 52,800 | 4,929,413 | Jan 11, 2022, 03:29 PM |
Cambrian BioPharma Inc | 10% Owner | Jan 10, 2022 | Buy | $5.28 | 10,000 | 52,800 | 4,929,413 | Jan 11, 2022, 03:22 PM |
Peyer James | Director | Dec 30, 2021 | Buy | $4.85 | 1,127 | 5,466 | 4,919,413 | Jan 03, 2022, 09:40 AM |
Cambrian BioPharma Inc | 10% Owner | Dec 30, 2021 | Buy | $4.85 | 1,127 | 5,466 | 4,919,413 | Jan 03, 2022, 09:38 AM |
Peyer James | Director | Dec 29, 2021 | Buy | $4.98 | 69,000 | 343,620 | 4,918,286 | Dec 30, 2021, 12:25 PM |
Cambrian BioPharma Inc | 10% Owner | Dec 29, 2021 | Buy | $4.98 | 69,000 | 343,620 | 4,918,286 | Dec 30, 2021, 12:24 PM |
Peyer James | Director | Dec 28, 2021 | Buy | $5.28 | 11,288 | 59,601 | 4,849,286 | Dec 29, 2021, 12:04 PM |
Cambrian BioPharma Inc | 10% Owner | Dec 28, 2021 | Buy | $5.28 | 11,288 | 59,601 | 4,849,286 | Dec 29, 2021, 11:37 AM |
Peyer James | Director | Dec 27, 2021 | Buy | $5.30 | 3,712 | 19,674 | 4,837,998 | Dec 27, 2021, 06:08 PM |
Cambrian BioPharma Inc | 10% Owner | Dec 27, 2021 | Buy | $5.30 | 3,712 | 19,674 | 4,837,998 | Dec 27, 2021, 06:04 PM |
Peyer James | Director | Dec 23, 2021 | Buy | $5.27 | 11,000 | 57,970 | 4,834,286 | Dec 23, 2021, 06:55 PM |
Cambrian BioPharma Inc | 10% Owner | Dec 23, 2021 | Buy | $5.27 | 11,000 | 57,970 | 4,834,286 | Dec 23, 2021, 06:53 PM |
Peyer James | Director | Dec 17, 2021 | Buy | $5.29 | 117 | 619 | 4,823,286 | Dec 21, 2021, 03:54 PM |
Cambrian BioPharma Inc | 10% Owner | Dec 17, 2021 | Buy | $5.29 | 117 | 619 | 4,823,286 | Dec 21, 2021, 03:48 PM |
Cambrian BioPharma Inc | 10% Owner | Dec 16, 2021 | Buy | $5.25 | 10,925 | 57,356 | 4,823,169 | Dec 20, 2021, 05:23 PM |
Peyer James | Director | Dec 16, 2021 | Buy | $5.25 | 10,925 | 57,356 | 4,823,169 | Dec 20, 2021, 05:18 PM |
RICKS THOMAS G | Director | Dec 09, 2021 | Buy | $6.62 | 20,000 | 132,400 | 321,769 | Dec 13, 2021, 04:15 PM |
RICKS THOMAS G | Director | Dec 10, 2021 | Buy | $5.86 | 20,000 | 117,200 | 341,769 | Dec 13, 2021, 04:15 PM |
Pierce Robert Hamilton | Chief Scientific Officer | Aug 11, 2021 | Sale | $7.34 | 16,030 | 117,718 | 0 | Aug 12, 2021, 05:07 PM |
Pierce Robert Hamilton | Chief Scientific Officer | Aug 10, 2021 | Sale | $7.13 | 66,350 | 473,003 | 16,030 | Aug 10, 2021, 05:40 PM |
Pierce Robert Hamilton | Chief Scientific Officer | Aug 09, 2021 | Sale | $7.06 | 6,982 | 49,295 | 82,380 | Aug 10, 2021, 05:40 PM |
Pierce Robert Hamilton | Chief Scientific Officer | Aug 06, 2021 | Sale | $7.11 | 6,460 | 45,948 | 89,362 | Aug 10, 2021, 05:40 PM |
Peyer James | Director | May 05, 2021 | Buy | $12.00 | 350 | 4,200 | 4,812,244 | May 06, 2021, 04:34 PM |
Cambrian BioPharma Inc | 10% Owner | Apr 20, 2021 | Buy | $12.77 | 385 | 4,916 | 4,811,894 | Apr 21, 2021, 03:52 PM |
Peyer James | Director | Apr 19, 2021 | Buy | $13.38 | 1,965 | 26,292 | 4,811,509 | Apr 20, 2021, 03:37 PM |
Cambrian BioPharma Inc | 10% Owner | Apr 19, 2021 | Buy | $13.38 | 1,965 | 26,292 | 4,811,509 | Apr 20, 2021, 03:31 PM |
Cambrian BioPharma Inc | 10% Owner | Apr 13, 2021 | Buy | $14.00 | 2,000 | 28,000 | 4,809,544 | Apr 14, 2021, 05:00 PM |
Peyer James | Director | Apr 13, 2021 | Buy | $14.00 | 2,000 | 28,000 | 4,809,544 | Apr 14, 2021, 04:41 PM |
Peyer James | Director | Apr 07, 2021 | Buy | $14.00 | 2,000 | 28,000 | 4,807,544 | Apr 08, 2021, 06:13 PM |
Cambrian BioPharma Inc | 10% Owner | Apr 01, 2021 | Buy | $14.00 | 1,000 | 14,000 | 4,805,544 | Apr 02, 2021, 02:58 PM |
Peyer James | Director | Apr 01, 2021 | Buy | $14.00 | 1,000 | 14,000 | 4,805,544 | Apr 02, 2021, 02:56 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 30, 2021 | Buy | $12.00 | 2,000 | 24,000 | 4,804,544 | Mar 31, 2021, 03:43 PM |
Peyer James | Director | Mar 30, 2021 | Buy | $12.00 | 2,000 | 24,000 | 4,804,544 | Mar 31, 2021, 03:41 PM |
Peyer James | Director | Mar 24, 2021 | Buy | $14.12 | 3,750 | 52,950 | 4,802,544 | Mar 25, 2021, 12:40 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 24, 2021 | Buy | $14.12 | 3,750 | 52,950 | 4,802,544 | Mar 25, 2021, 12:37 PM |
Peyer James | Director | Mar 23, 2021 | Buy | $14.34 | 10,000 | 143,400 | 4,798,794 | Mar 24, 2021, 04:21 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 23, 2021 | Buy | $14.34 | 10,000 | 143,400 | 4,798,794 | Mar 24, 2021, 04:19 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 22, 2021 | Buy | $15.02 | 2,183 | 32,789 | 4,788,794 | Mar 23, 2021, 12:34 PM |
Peyer James | Director | Mar 22, 2021 | Buy | $15.02 | 2,183 | 32,789 | 4,788,794 | Mar 23, 2021, 12:32 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 18, 2021 | Buy | $15.25 | 817 | 12,459 | 4,786,611 | Mar 19, 2021, 03:51 PM |
Peyer James | Director | Mar 18, 2021 | Buy | $15.25 | 817 | 12,459 | 4,786,611 | Mar 19, 2021, 03:44 PM |
Peyer James | Director | Mar 08, 2021 | Buy | $15.25 | 1,000 | 15,249 | 4,785,794 | Mar 10, 2021, 05:37 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 08, 2021 | Buy | $15.25 | 1,000 | 15,249 | 4,785,794 | Mar 10, 2021, 05:35 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 05, 2021 | Buy | $13.75 | 8,000 | 110,000 | 4,784,794 | Mar 08, 2021, 04:55 PM |
Peyer James | Director | Mar 05, 2021 | Buy | $13.75 | 8,000 | 110,000 | 4,784,794 | Mar 08, 2021, 04:48 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 04, 2021 | Buy | $14.13 | 2,000 | 28,250 | 4,776,794 | Mar 05, 2021, 01:57 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 03, 2021 | Buy | $15.85 | 3,000 | 47,550 | 4,774,794 | Mar 05, 2021, 01:57 PM |
Peyer James | Director | Mar 04, 2021 | Buy | $14.13 | 2,000 | 28,250 | 4,776,794 | Mar 05, 2021, 01:55 PM |
Peyer James | Director | Mar 03, 2021 | Buy | $15.85 | 3,000 | 47,550 | 4,774,794 | Mar 05, 2021, 01:55 PM |
Peyer James | Director | Mar 02, 2021 | Buy | $16.25 | 3,000 | 48,750 | 4,771,794 | Mar 03, 2021, 05:22 PM |
Cambrian BioPharma Inc | 10% Owner | Mar 02, 2021 | Buy | $16.25 | 3,000 | 48,750 | 4,771,794 | Mar 03, 2021, 12:00 AM |
Peyer James | Director | Feb 26, 2021 | Buy | $16.25 | 5,000 | 81,250 | 4,768,794 | Mar 02, 2021, 04:15 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 26, 2021 | Buy | $16.25 | 5,000 | 81,250 | 4,768,794 | Mar 02, 2021, 04:15 PM |
Peyer James | Director | Feb 25, 2021 | Buy | $15.79 | 12,000 | 189,480 | 4,763,794 | Feb 26, 2021, 04:05 PM |
Peyer James | Director | Feb 24, 2021 | Buy | $16.91 | 19,000 | 321,382 | 4,751,794 | Feb 26, 2021, 04:05 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 25, 2021 | Buy | $15.79 | 12,000 | 189,480 | 4,763,794 | Feb 26, 2021, 04:05 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 24, 2021 | Buy | $16.91 | 19,000 | 321,382 | 4,751,794 | Feb 26, 2021, 04:05 PM |
Peyer James | Director | Feb 23, 2021 | Buy | $17.79 | 20,300 | 361,070 | 4,732,794 | Feb 25, 2021, 05:55 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 23, 2021 | Buy | $17.79 | 20,300 | 361,070 | 4,732,794 | Feb 25, 2021, 05:55 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 22, 2021 | Buy | $18.88 | 9,802 | 185,062 | 4,712,494 | Feb 24, 2021, 08:32 PM |
Peyer James | Director | Feb 22, 2021 | Buy | $18.88 | 9,802 | 185,062 | 4,712,494 | Feb 24, 2021, 08:27 PM |
Peyer James | Director | Feb 19, 2021 | Buy | $19.77 | 11,786 | 233,009 | 4,702,692 | Feb 23, 2021, 04:15 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 19, 2021 | Buy | $19.77 | 11,786 | 233,009 | 4,702,692 | Feb 23, 2021, 04:15 PM |
Peyer James | Director | Feb 18, 2021 | Buy | $19.75 | 753 | 14,872 | 4,690,906 | Feb 19, 2021, 04:15 PM |
Cambrian BioPharma Inc | 10% Owner | Feb 18, 2021 | Buy | $19.75 | 753 | 14,872 | 4,690,906 | Feb 19, 2021, 04:15 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 143,508 | 0.00015% | 71.25% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 136,318 | 0.00001% | No change | Other |
DUQUESNE FAMILY OFFICE LLC | 100,000 | 0.00206% | No change | Other |
BLACKROCK INC. | 34,813 | 0% | -1.17% | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View